AU5102493A - A method for the detection and treatment of prostate disease - Google Patents

A method for the detection and treatment of prostate disease

Info

Publication number
AU5102493A
AU5102493A AU51024/93A AU5102493A AU5102493A AU 5102493 A AU5102493 A AU 5102493A AU 51024/93 A AU51024/93 A AU 51024/93A AU 5102493 A AU5102493 A AU 5102493A AU 5102493 A AU5102493 A AU 5102493A
Authority
AU
Australia
Prior art keywords
detection
treatment
prostate disease
prostate
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51024/93A
Inventor
Daniel Djakiew
Michael E Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon LLC
Georgetown University
Original Assignee
Cephalon LLC
Georgetown University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon LLC, Georgetown University filed Critical Cephalon LLC
Publication of AU5102493A publication Critical patent/AU5102493A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/48Nerve growth factor [NGF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU51024/93A 1992-09-11 1993-09-09 A method for the detection and treatment of prostate disease Abandoned AU5102493A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94351292A 1992-09-11 1992-09-11
US943512 1992-09-11
PCT/US1993/008446 WO1994006935A1 (en) 1992-09-11 1993-09-09 A method for the detection and treatment of prostate disease

Publications (1)

Publication Number Publication Date
AU5102493A true AU5102493A (en) 1994-04-12

Family

ID=25479795

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51024/93A Abandoned AU5102493A (en) 1992-09-11 1993-09-09 A method for the detection and treatment of prostate disease

Country Status (5)

Country Link
EP (1) EP0673438A1 (en)
JP (1) JPH08506654A (en)
AU (1) AU5102493A (en)
CA (1) CA2143945A1 (en)
WO (1) WO1994006935A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011253A1 (en) * 1993-10-18 1995-04-27 The Walter And Eliza Hall Institute Of Medical Research A method for enhancing neurone survival and agents useful for same
AU689145B2 (en) * 1993-10-18 1998-03-26 Walter And Eliza Hall Institute Of Medical Research, The A method for enhancing neurone survival and agents useful for same

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548062B2 (en) * 2000-02-29 2003-04-15 Cephalon, Inc. Method of treating cancer with anti-neurotrophin agents
FR2846426B1 (en) 2002-10-28 2004-12-10 Bio Merieux METHOD FOR ASSAYING NGF FOR IN VITRO DIAGNOSIS OF BREAST CANCER AND USE IN THERAPY

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782015A (en) * 1984-03-30 1988-11-01 Syntex (U.S.A.) Inc. Method for determining the presence of malignant cells

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011253A1 (en) * 1993-10-18 1995-04-27 The Walter And Eliza Hall Institute Of Medical Research A method for enhancing neurone survival and agents useful for same
AU689145B2 (en) * 1993-10-18 1998-03-26 Walter And Eliza Hall Institute Of Medical Research, The A method for enhancing neurone survival and agents useful for same

Also Published As

Publication number Publication date
WO1994006935A1 (en) 1994-03-31
JPH08506654A (en) 1996-07-16
CA2143945A1 (en) 1994-03-31
EP0673438A1 (en) 1995-09-27

Similar Documents

Publication Publication Date Title
AU5616894A (en) Method and device for treating and enlarging body lumens
AU5268696A (en) Novel compounds and methods for therapy
AU4995693A (en) Apparatus and method for the treatment of blood
AU6965996A (en) Method and apparatus for maintaining the position of body parts
AU7791594A (en) Illuminator and method for photodynamic therapy
AU7379896A (en) Method and apparatus for improving the function of sensory cells
ZA957483B (en) Compounds and methods for the treatment of cancer
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
AU1585999A (en) Methods for the detection and treatment of disease using a glycosyltransferase
AU661254B2 (en) Atrial defibrillator and method for providing atrial sensing
ZA956993B (en) Methods of inhibiting demyelinating and desmyelinating diseases.
IL107005A (en) Method for the detection and differentiation of neoplastic tissue
AU7816694A (en) Method and system for the treatment of seeds and bulbs
EP0761718A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
AU5543494A (en) Method and kit for cancer diagnosis
AU1394795A (en) Method and device for the continuous cooking of pulp
AU4407093A (en) Method and apparatus for prostatic treatment
AU4489693A (en) Apparatus and methods for improved construction
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
AU1104392A (en) Method for the treatment of hepatic failure and disease
EP0761721A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
AU5102493A (en) A method for the detection and treatment of prostate disease
AU3973793A (en) Method of treating cancer
AU3177893A (en) Method for diagnosing and treating cancer
AU1225492A (en) Process for the detection and localization of cancer